RESEARCH-USE BIOSIMILAR ANTIBODY
Depatuxizumab
Antibody-drug conjugate · IgG1
Depatuxizumab is a brain-penetrant and humanized tumor-specific anti EGFR monoclonal antibody. Depatuxizumab inhibits the growth of xenograft models of mutant EGFRvIII and wild-type EGFR. Depatuxizumab can be used for research on cancer.
TARGETEGFR
YAntibody-drug conjugate
CATALOGSC-BS-629
CATALOG NUMBERSC-BS-629
MOLECULAR WEIGHTApprox. 144.54 kDa
PRODUCT FORMATAntibody-drug conjugate
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Depatuxizumab is a brain-penetrant and humanized tumor-specific anti EGFR monoclonal antibody. Depatuxizumab inhibits the growth of xenograft models of mutant EGFRvIII and wild-type EGFR. Depatuxizumab can be used for research on cancer.
Depatuxizumab is a recombinant research-use antibody directed against EGFR.